Retrospective Evaluation of Prognosis of Pci Patients Using Network Data in SHengjing Hospital
R-PUSH
1 other identifier
observational
3,000
1 country
1
Brief Summary
Coronary heart disease (CHD) has a serious health threaten to population. PCI is a well-proved measure in CHD management. However, the knowledge about the real-life PCI use and how evidence-based therapies in routine clinical practice is limited. In a large-scale hospital in Northeast China, the investigators will examine various factors of 3007 consecutive PCI inpatient cases from January 1, 2010 to October 31, 2014. The medical records will be reviewed and abstracted to evaluate the clinical treatment pattern and outcomes. Basic data and innovative evidence will accelerate evidence-based clinical practice, and improve patients' outcomes in future finally.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 19, 2016
CompletedFirst Posted
Study publicly available on registry
January 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedJanuary 28, 2016
January 1, 2016
4 years
January 19, 2016
January 25, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of Participants with Major adverse cardiovascular events (MACE)
Composite of major adverse cardiovascular events (MACE) includes cardiac death, non-fatal AMI, coronary revascularization procedure.
5 years
Secondary Outcomes (8)
Percentage of Participants with all-cause death
5 years
Percentage of Participants with cardiac death
5 years
Percentage of Participants with non-fatal AMI
5 years
Percentage of Participants with coronary revascularization
5 years
Percentage of Participants with stroke
5 years
- +3 more secondary outcomes
Study Arms (1)
patients receiving PCI
patients receiving percutaneous coronary intervention(PCI)
Interventions
Eligibility Criteria
patients receiving PCI in department of Cardiology,Shengjing Hospital of China Medical University from January 1, 2010 to October 31, 2014
You may qualify if:
- Hospitalized patients undergoing a percutaneous coronary intervention (PCI) for coronary lesions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shengjing Hospital
Shenyang, Liaoning, 110004, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
tongtong yu, Doctor
Shengjing Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- attending physician
Study Record Dates
First Submitted
January 19, 2016
First Posted
January 28, 2016
Study Start
October 1, 2015
Primary Completion
October 1, 2019
Study Completion
October 1, 2019
Last Updated
January 28, 2016
Record last verified: 2016-01
Data Sharing
- IPD Sharing
- Will not share
We will not share IPD to protect our data very well.